Elly Marcq

1.0k total citations
33 papers, 697 citations indexed

About

Elly Marcq is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Elly Marcq has authored 33 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 9 papers in Immunology. Recurrent topics in Elly Marcq's work include Cancer Immunotherapy and Biomarkers (11 papers), Occupational and environmental lung diseases (9 papers) and Advanced Chemical Sensor Technologies (5 papers). Elly Marcq is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Occupational and environmental lung diseases (9 papers) and Advanced Chemical Sensor Technologies (5 papers). Elly Marcq collaborates with scholars based in Belgium, Australia and Netherlands. Elly Marcq's co-authors include Evelien Smits, Patrick Pauwels, Jonas R.M. Van Audenaerde, Jorrit De Waele, Jan P. van Meerbeeck, Eva Lion, Vasiliki Siozopoulou, Filip Lardon, Jinthe Van Loenhout and Karen Zwaenepoel and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Elly Marcq

30 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elly Marcq Belgium	15	307	246	225	130	93	33	697
Jonas R.M. Van Audenaerde Belgium	15	365 1.2×	177 0.7×	273 1.2×	132 1.0×	158 1.7×	24	722
Alexander Filatenkov United States	10	339 1.1×	118 0.5×	303 1.3×	89 0.7×	93 1.0×	19	647
Carl Power Australia	18	227 0.7×	166 0.7×	222 1.0×	106 0.8×	296 3.2×	33	805
Jacqueline Douglass United States	10	497 1.6×	257 1.0×	271 1.2×	103 0.8×	258 2.8×	23	811
Stefan S. Kachala United States	11	300 1.0×	386 1.6×	114 0.5×	65 0.5×	129 1.4×	20	713
Ernest Dodoo Sweden	15	314 1.0×	183 0.7×	335 1.5×	44 0.3×	213 2.3×	40	890
Gaurav Malviya Italy	16	173 0.6×	75 0.3×	107 0.5×	184 1.4×	162 1.7×	34	620
Andreas Poschenrieder Germany	10	319 1.0×	86 0.3×	167 0.7×	216 1.7×	178 1.9×	13	732
Amanda McWatters United States	14	191 0.6×	65 0.3×	112 0.5×	91 0.7×	221 2.4×	27	538
Ana Bocanegra Spain	18	697 2.3×	165 0.7×	549 2.4×	37 0.3×	222 2.4×	36	1.1k

Countries citing papers authored by Elly Marcq

Since Specialization

Citations

This map shows the geographic impact of Elly Marcq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elly Marcq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elly Marcq more than expected).

Fields of papers citing papers by Elly Marcq

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elly Marcq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elly Marcq. The network helps show where Elly Marcq may publish in the future.

Co-authorship network of co-authors of Elly Marcq

This figure shows the co-authorship network connecting the top 25 collaborators of Elly Marcq. A scholar is included among the top collaborators of Elly Marcq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elly Marcq. Elly Marcq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Audenaerde, Jonas R.M. Van, Jorrit De Waele, Christophe Hermans, et al.. (2025). Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma. OncoImmunology. 14(1). 2512104–2512104.

Wener, Reinier, Jan P. van Meerbeeck, Jo Raskin, et al.. (2025). Differentiating benign and malignant solitary pulmonary nodules through exhaled breath analysis. ERJ Open Research. 12(1). 827–2025.

Elaskalani, Omar, Ben Wylie, Caitlin M. Tilsed, et al.. (2024). Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade. Journal for ImmunoTherapy of Cancer. 12(9). e008568–e008568. 2 indexed citations

Fisher, Scott, Elly Marcq, Timothy E. Miller, et al.. (2024). The MexTAg collaborative cross: host genetics affects asbestos related disease latency, but has little influence once tumours develop. SHILAP Revista de lepidopterología. 6. 1373003–1373003.

Siozopoulou, Vasiliki, Evelien Smits, Karen Zwaenepoel, et al.. (2023). Pd-1, Pd-L1, Ido, Cd70 and Microsatellite Instability as Potential Targets to Prevent Immune Evasion in Sarcomas. Immunotherapy. 15(15). 1257–1273. 3 indexed citations

Boullosa, Laurie Freire, Jinthe Van Loenhout, Tal Flieswasser, et al.. (2023). Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers. Antioxidants. 12(3). 667–667. 16 indexed citations

Janssens, Eline, Tom Richart, Veerle Surmont, et al.. (2023). Determining the clinical utility of a breath test for screening an asbestos-exposed population for pleural mesothelioma: baseline results. Journal of Breath Research. 17(4). 47105–47105. 5 indexed citations

Janssens, Annelies, Jo Raskin, Patrick Pauwels, et al.. (2022). Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma. Biomedicines. 10(3). 673–673. 5 indexed citations

Siozopoulou, Vasiliki, Elly Marcq, Koen De Winne, et al.. (2022). NTRK Fusions in a Sarcomas Series: Pathology, Molecular and Clinical Aspects. Pathology & Oncology Research. 28. 1610423–1610423. 7 indexed citations

10.

Boullosa, Laurie Freire, Jinthe Van Loenhout, Christophe Hermans, et al.. (2022). Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model. Pharmaceutics. 14(12). 2761–2761. 7 indexed citations

11.

Lin, Abraham, Joey De Backer, Delphine Quatannens, et al.. (2022). The effect of local non‐thermal plasma therapy on the cancer‐immunity cycle in a melanoma mouse model. Bioengineering & Translational Medicine. 7(3). e10314–e10314. 22 indexed citations

12.

Janssens, Eline, Karim Vermaelen, Jan P. van Meerbeeck, et al.. (2022). Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath Research. Frontiers in Oncology. 12. 851785–851785. 9 indexed citations

13.

Siozopoulou, Vasiliki, Evelien Smits, Koen De Winne, Elly Marcq, & Patrick Pauwels. (2021). NTRK Fusions in Sarcomas: Diagnostic Challenges and Clinical Aspects. Diagnostics. 11(3). 478–478. 29 indexed citations

14.

Marcq, Elly, Jonas R.M. Van Audenaerde, Jorrit De Waele, et al.. (2021). The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3. Cancers. 13(2). 282–282. 23 indexed citations

15.

Fisher, Scott, Carolyn J. Peddle‐McIntyre, Robert U. Newton, et al.. (2020). Voluntary exercise in mesothelioma: effects on tumour growth and treatment response in a murine model. BMC Research Notes. 13(1). 435–435. 2 indexed citations

16.

Audenaerde, Jonas R.M. Van, Elly Marcq, Bianca von Scheidt, et al.. (2020). Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment. Clinical & Translational Immunology. 9(8). e1165–e1165. 28 indexed citations

17.

Siozopoulou, Vasiliki, Elly Marcq, Julie Jacobs, et al.. (2019). Desmoid tumors display a strong immune infiltration at the tumor margins and no PD-L1-driven immune suppression. Cancer Immunology Immunotherapy. 68(10). 1573–1583. 14 indexed citations

18.

Marcq, Elly, et al.. (2018). Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer. Frontiers in Immunology. 9. 394–394. 75 indexed citations

19.

Marcq, Elly, Patrick Pauwels, Jan P. van Meerbeeck, & Evelien Smits. (2015). Targeting immune checkpoints: New opportunity for mesothelioma treatment?. Cancer Treatment Reviews. 41(10). 914–924. 35 indexed citations

20.

Silva-Gomes, Rita, Elly Marcq, Carine M. Gonçalves, et al.. (2015). Spontaneous Healing of Mycobacterium ulcerans Lesions in the Guinea Pig Model. PLoS neglected tropical diseases. 9(12). e0004265–e0004265. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact